Abraxane added to Gemzar helps in metastatic pancreatic cancer

Preliminary results of a recent clinical trial shows a survival benefit when Abraxane (modified Taxol) is added to Gemzar for treatment of metastatic pancreatic cancer.  Full results of the study to be announced in January 2014.